WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001001995) METHOD FOR TREATMENT OF ASTHMA SYNDROME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/001995    International Application No.:    PCT/US2000/018508
Publication Date: 11.01.2001 International Filing Date: 06.07.2000
Chapter 2 Demand Filed:    02.02.2001    
IPC:
A61K 31/122 (2006.01), A61K 31/575 (2006.01), A61K 35/37 (2006.01), A61K 35/413 (2006.01), A61K 35/50 (2006.01), A61K 35/55 (2006.01)
Applicants: NUTRICOLOGY, INC. [US/US]; 30806 Santana Street, Hayward, CA 94544 (US)
Inventors: HOANG, Ba, X.; (US).
LEVINE, Stephen, A.; (US)
Agent: GENCARELLA, Michael, L.; Iota Pi Law Group, P.O. Box 60850, Palo Alto, CA 94306-0850 (US).
VOSSIUS & PARTNER; Siebertstrasse 4, D-81765 Munich (DE)
Priority Data:
60/142,482 06.07.1999 US
Title (EN) METHOD FOR TREATMENT OF ASTHMA SYNDROME
(FR) METHODE DE TRAITEMENT DE L'ASTHME
Abstract: front page image
(EN)A method of treating asthma in a patient is disclosed. The method includes administering to the patient, a therapeutically effective amount of (i) Moschus moschiferus or its active ingredient muscone, (ii) Calculus Bovis or its major active ingredients cholic acid and urodesoxychloic acid, or (iii) Placental extract or powder from humans or mammals. The compound is preferably administered orally, twice or three time a day.
(FR)L'invention concerne une méthode de traitement de l'asthme, consistant à administrer à un patient une dose efficace d'un point de vue thérapeutique de (i) Moschus moschiferus ou de son agent actif, la muscone, de (ii) Calculus Bovis ou de ses principaux agents actifs, l'acide cholique et l'acide urodésoxychloïque, ou (iii) des extraits ou des poudres placentaires d'homme ou de mammifère. Ce composé est administré de préférence par voie orale, deux ou trois fois par jour.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)